Episode 46: Precision Medicine, Biomarkers and Genitourinary Cancers

Biomarkers are windows into health, like a cholesterol or PSA test. Precision medicine biomarkers enable us to refine clinical targets, and identify more precise cancer risks, diagnoses & treatments. This new health care trend translates into better cancer care & reduced collateral damage, especially for prostate cancer.



Jeffrey J. Tosoian, MD, MPH Assistant Professor and Director of Translational Cancer Research, Department of Urology, Vanderbilt University Medical Center, Nashville TN. Dr. Tosian’s research is focused on the development and clinical application of diagnostic and prognostic tools, including blood-, urine-, and tissue-based biomarkers, to guide detection and management of genitourinary cancers.

Social Media



2356 232